In the pursuit of global harmonization in pharmaceutical regulation, Japan which is renowned for its meticulous standards and innovative spirit, has taken a significant step by implementing the Electronic Common Technical Document (eCTD) v4.0. This move aligns Japan with international standards set by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human […]
Japan’s Approach to eCTD V4.0 Read More »
The accelerated approval pathway is established to expedite the availability of drugs for serious or life-threatening conditions. It allows the FDA to approve treatments based on surrogate or intermediate endpoints before confirmatory studies are completed. This pathway has been instrumental in advancing treatments for rare diseases and unmet medical needs, relying on a balance between
Does the FDA need a new approval pathway? Read More »
The convergence of healthcare with technology has led to giant innovations, one of the most significant being the use of software and artificial intelligence (AI) as medical devices. Such developments have been called Software as a Medical Device (SaMD) by many and have wide applicability in transforming the diagnosis, treatment, and care of patients medically.
Regulatory Framework for Software and Artificial Intelligence as Medical Device Read More »
In the early days of drug development, pioneers had two routes: the traditional New Drug Application (NDA) or its generic type, the Abbreviated New Drug Application (ANDA). The NDA involved extensive original comprehensive research and clinical trials, while the ANDA was a well-travelled path for a generic drug, relied on safety and efficacy data of
Navigating the 505(b)(2) Approval Pathway Read More »
In vitro diagnostic medical devices (IVD devices) are an integral part of the healthcare system. They are typically used to analyze samples that are collected from the human body (i.e., saliva, blood, tissue, and urine) and help in diagnosing, screening, and monitoring various conditions. IVD devices are subjected to different regulations that specify different requirements
Specifications for In Vitro Diagnostic Devices Read More »
Improving access to clinical trial information is critical in order to advance medical research while also ensuring patient safety. Enhanced transparency can not only accelerate innovation but also empower various stakeholders to make appropriate and informed decisions in order to progress medical research forward. The European Medicines Agency (EMA) has introduced several improvements in the
Faster Access to Clinical Trial Information in Europe Read More »
When it comes to ensuring the safety and effectiveness of medical devices intended to deliver drugs, understanding Essential Drug Delivery Outputs (EDDO) is important. The advent of drug-device combination products has necessitated the development of robust guidelines to ensure safety, efficacy, and performance. One such crucial aspect of these combination products is the Essential Drug
The Use of EDDO to Ensure Drug Delivery Function Read More »
Pharmacovigilance practices are associated with several challenges related to collection of safety data, processing, assessment, and volume of patient safety data. As technological disruptors- like artificial intelligence (AI)- develop, so do the solutions to tackle such challenges. This leads to more efficient pharmacovigilance (PV) systems and processes that ultimately enhance drug safety monitoring. Whether it
Emerging Drug Safety Technology Program Read More »
At DDReg, we believe in nurturing a strong company culture that celebrates our shared values and national pride. We had the privilege of commemorating the 77th Indian Independence Day at our headquarters, where the team came together for a day filled with joy, unity, and patriotism. Independence Day Celebrations- Patriotism, Team Building and Festive Fun
DDReg Celebrates 77th Independence Day Read More »
Transparency in Machine Learning-Enabled Medical Devices (MLMDs) refers to the degree to which relevant information about a device—such as its intended use, the development process, performance, and logic—is clearly communicated to stakeholders. Why is this important? To help the development of safe, effective, and high-quality AI/ML learning technologies. These may learn from real-world data and
Ensuring Transparency for Machine Learning-Enabled Medical Devices Read More »
